Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid
Abstract is missing (Short communication)
Saved in:
Main Authors: | Päivi Leisti (Author), Anna Pankakoski (Author), Jari Jokelainen (Author), Laura Huilaja (Author), Jaana Panelius (Author), Kaisa Tasanen (Author), Outi Varpuluoma (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid
by: Outi Lindgren, et al.
Published: (2019) -
Bullous Pemphigoid in Three Paediatric Patients in Finland
by: Anna Pankakoski, et al.
Published: (2020) -
Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges
by: Kluger N, et al.
Published: (2020) -
Linagliptin-Associated Bullous Pemphigoid: The First Case in China
by: Yang-Chun Liu, et al.
Published: (2020) -
Ulcerative Tuberculosis in a Patient Treated with Adalimumab
by: Outi Varpuluoma, et al.
Published: (2022)